BENTSUR RON

CEO at XTL BIOPHARMACEUTICALS LTD · on record since Aug 28, 2006
Director at KERYX BIOPHARMACEUTICALS INC · on record since Jun 24, 2009
Director at STEMLINE THERAPEUTICS INC · on record since Jan 28, 2013
Director at Beyond Air, Inc. · on record since Jun 20, 2017
Director at UroGen Pharma Ltd. · on record since Jan 10, 2019
Chief Executive Officer at UroGen Pharma Ltd. · on record since Jan 10, 2019
Director at Nuvectis Pharma, Inc. · on record since Mar 29, 2022
Chairman & CEO at Nuvectis Pharma, Inc. · on record since Mar 29, 2022
10% owner at Nuvectis Pharma, Inc. · on record since Mar 29, 2022
Vice President at KERYX BIOPHARMACEUTICALS INC · on record since Apr 27, 2005

Insider trading activity of BENTSUR RON

Transactions on record: 222; since Apr 27, 2005

Open-market buys: 91; $3M

Open-market sells: 64; $13.6M

Companies traded: 5; last filing Jul 1, 2026

Figures computed from official regulatory filings — .

Companies where BENTSUR RON has traded

Nuvectis Pharma, Inc.81 tx · $2.7M · Jul 1, 2026
Beyond Air, Inc.53 tx · $2.1M · Nov 26, 2024
STEMLINE THERAPEUTICS INC18 tx · $44.5K · Jun 10, 2020
KERYX BIOPHARMACEUTICALS INC68 tx · $12.3M · Apr 8, 2015
XTL BIOPHARMACEUTICALS LTD2 tx · $24.6K · Aug 21, 2007

Track record of BENTSUR RON

Statistical track record

Free account

Open-market buys: 93

Last buy: Jun 30, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BENTSUR RON

Co-insiders of BENTSUR RON

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Nuvectis Pharma, Inc.Listing on record	Jul 1, 2026	Buy	12,500	20.00 USD	$250K	conv 46Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	Jan 9, 2026	Award	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Nov 6, 2025	Buy	5,000	5.72 USD	$28.6K	conv 49Cluster	SEC
Nuvectis Pharma, Inc.Listing on record	Jan 3, 2025	Award	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Dec 26, 2024	Buy	4,500	4.65 USD	$20.9K	conv 43Cluster	SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-45,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	24,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	45,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-24,000	—	n/a (No price was disclosed in the filing)		SEC
Nuvectis Pharma, Inc.Listing on record	Nov 18, 2024	Buy	20,000	4.92 USD	$98.4K	conv 58Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	May 15, 2024	Buy	1,940	6.74 USD	$13.1K	conv 42Cluster	SEC
Nuvectis Pharma, Inc.Listing on record	May 13, 2024	Buy	2,000	6.40 USD	$12.8K	conv 44Cluster	SEC
Beyond Air, Inc.Listing on record	Mar 21, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Mar 19, 2024	Buy	5,000	10.29 USD	$51.4K	conv 46Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 12, 2023	Buy	640	11.08 USD	$7.1K	conv 29	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 10, 2023	Buy	830	11.19 USD	$9.3K	conv 33	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 10, 2023	Buy	250	11.27 USD	$2.8K	conv 26	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Nuvectis Pharma, Inc.Listing on record	Jul 1, 2026	Buy	12,500	20.00 USD	$250K	conv 46Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	Jan 9, 2026	Award	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Nov 6, 2025	Buy	5,000	5.72 USD	$28.6K	conv 49Cluster	SEC
Nuvectis Pharma, Inc.Listing on record	Jan 3, 2025	Award	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Dec 26, 2024	Buy	4,500	4.65 USD	$20.9K	conv 43Cluster	SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-45,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	24,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	AwardD (derivative)	45,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Beyond Air, Inc.Listing on record	Nov 26, 2024	OtherD (derivative)	-24,000	—	n/a (No price was disclosed in the filing)		SEC
Nuvectis Pharma, Inc.Listing on record	Nov 18, 2024	Buy	20,000	4.92 USD	$98.4K	conv 58Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	May 15, 2024	Buy	1,940	6.74 USD	$13.1K	conv 42Cluster	SEC
Nuvectis Pharma, Inc.Listing on record	May 13, 2024	Buy	2,000	6.40 USD	$12.8K	conv 44Cluster	SEC
Beyond Air, Inc.Listing on record	Mar 21, 2024	AwardD (derivative)	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Nuvectis Pharma, Inc.Listing on record	Mar 19, 2024	Buy	5,000	10.29 USD	$51.4K	conv 46Unusual size	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 12, 2023	Buy	640	11.08 USD	$7.1K	conv 29	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 10, 2023	Buy	830	11.19 USD	$9.3K	conv 33	SEC
Nuvectis Pharma, Inc.Listing on record	Oct 10, 2023	Buy	250	11.27 USD	$2.8K	conv 26	SEC